Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000308716 | SCV000399311 | uncertain significance | Brittle cornea syndrome 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002436173 | SCV002751946 | uncertain significance | Cardiovascular phenotype | 2020-08-26 | criteria provided, single submitter | clinical testing | The c.2951_2953delACG variant (also known as p.D984del) is located in coding exon 1 of the ZNF469 gene. This variant results from an in-frame ACG deletion at nucleotide positions 2951 to 2953. This results in the in-frame deletion of an aspartic acid at codon 984. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV002522895 | SCV002959682 | uncertain significance | not provided | 2022-08-06 | criteria provided, single submitter | clinical testing | This variant, c.2951_2953del, results in the deletion of 1 amino acid(s) of the ZNF469 protein (p.Asp984del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ZNF469-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |